Provided by Tiger Trade Technology Pte. Ltd.

Edgewise Therapeutics, Inc.

41.40
+0.92002.27%
Post-market: 41.400.00000.00%19:30 EDT
Volume:1.46M
Turnover:60.32M
Market Cap:4.50B
PE:-22.38
High:41.94
Open:41.01
Low:40.42
Close:40.48
52wk High:48.51
52wk Low:14.25
Shares:108.60M
Float Shares:88.17M
Volume Ratio:0.70
T/O Rate:1.66%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8502
EPS(LYR):-1.6302
ROE:-38.03%
ROA:-25.03%
PB:10.03
PE(LYR):-25.40

Loading ...

Edgewise Therapeutics to present at RBC Capital Markets Global Healthcare Conference

Reuters
·
May 12

Stifel Nicolaus Remains a Hold on Edgewise Therapeutics (EWTX)

TIPRANKS
·
May 11

Edgewise Therapeutics' Update for EDG-7500 Could Boost Shares, RBC Says

MT Newswires Live
·
May 09

Edgewise Therapeutics (EWTX) Receives a Buy from Evercore ISI

TIPRANKS
·
May 09

H.C. Wainwright Sticks to Its Buy Rating for Edgewise Therapeutics (EWTX)

TIPRANKS
·
May 08

Edgewise Therapeutics Shares Decline Amid Wider Q1 Loss

MT Newswires Live
·
May 07

Edgewise Therapeutics reports Q1 EPS (46c), consensus (49c)

TIPRANKS
·
May 07

Edgewise Therapeutics Q1 EPS $(0.46) Beats $(0.50) Estimate

Benzinga Earnings
·
May 07

Earnings Flash (EWTX) Edgewise Therapeutics Posts Q1 Net Loss $0.46 a Share, vs. FactSet Est of $0.49 Net Loss a Share

MT Newswires Live
·
May 07

Edgewise net loss widens to $49 million in Q1 FY26

Reuters
·
May 07

BRIEF-Edgewise Therapeutics Q1 Operating Expenses USD 54.115 Million

Reuters
·
May 07

Edgewise Therapeutics Q1 Operating Income USD -54.115 Million

THOMSON REUTERS
·
May 07

Press Release: Edgewise Therapeutics Reports First Quarter 2026 Financial Results and Advances Clinical Programs in Muscular Dystrophy and Cardiovascular Indications

Dow Jones
·
May 07

Why Edgewise Therapeutics (EWTX) Is Up 21.5% After Positive Trial, FDA Updates And Equity Grants

Simply Wall St.
·
May 07

Guggenheim Reaffirms Their Buy Rating on Edgewise Therapeutics (EWTX)

TIPRANKS
·
May 06

Wedbush Adjusts Price Target on Edgewise Therapeutics to $46 From $32, Maintains Outperform Rating

MT Newswires Live
·
May 06

Edgewise CMO Joanne M. Donovan disposes of common shares worth $2.09 million

Reuters
·
May 06

Edgewise Therapeutics rises 23.3%

TIPRANKS
·
May 05

BRIEF-Edgewise Therapeutics Reports Inducement Grants As Permitted By The Nasdaq Listing Rules

Reuters
·
May 04

Edgewise Therapeutics grants inducement stock options for 266,000 shares at $30.96 each

Reuters
·
May 04